BP
Bruce Prothro
Chief Regulatory Officer & SVP

Bruce Prothro insider trades: Arthrocare (ARTC) stock sales

Chief Regulatory Officer & SVP, Arthrocare Last trade Feb 3, 2014 8 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
6
Open-market trades
since 2012
1
Company
last trade 2014

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Bruce reports to the SEC

Open-market buys and sales

6 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 3, 2014ARTC↓ Sell$169K
Jan 8, 2014ARTC↓ Sell$1.5M
Jan 6, 2014ARTC↓ Sell$245K
Jun 18, 2013ARTC↓ Sell$90K
Jul 5, 2012ARTC↓ Sell$65K
Jan 3, 2012ARTC↓ Sell$150K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Bruce Prothro's insider trades

Bruce Prothro is Chief Regulatory Officer & SVP at Arthrocare (ARTC). Since Jan 3, 2012, Bruce has reported no open-market purchases and 6 sales worth $2.3M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (4 filings), shares returned to the company (2 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARTC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.